San Diego, May 13, 2020 – Beth Hoffman, CEO and President of Origami Therapeutics Inc has been announced as a panelist and speaker at the upcoming Advancing Women’s Leadership Skills & Opportunities In Pharma & Healthcare, currently scheduled to take place in Philadelphia from September 23-25, 2020. Through keynotes, panels, and unique mentoring breaks, this event shines a spotlight on influential women in Pharma and Healthcare, bringing industry role models and their journeys to the forefront. Featured speakers will share effective practices they’ve deployed to develop female talent and ideas for continued leadership development at all levels. More information about the Conference and its Agenda may be found here.

About Beth Hoffman

At Origami, Dr. Hoffman is leveraging lessons learned from her 20 years of CNS drug discovery to create a new approach to drug discovery for neurodegenerative diseases by “fixing broken proteins”. Prior to Origami she has held positions of increasing research and executive management responsibility at Eli Lilly, Amgen, and Vertex, she was a Research & Development executive at Amgen and Eli Lilly. Before entering the pharmaceutical industry, she led a research program at the National Institute of Mental Health.